-ISO 9001:2000

Orphan Drugs

Overlooking the profit motive & to make India self sufficient, we manufacture several orphan drugs which do not have adequate market potential, but are essential for the healthcare needs of the medical profession.

- - -


Cyan SOS
Back to Orphan Drugs
Cyanide Antidote Kit

Treatment of cyanide poisoning: The cyanide antidote kit first uses a small inhaled dose of amyl nitrite followed by intravenous sodium nitrite. This converts a portion of the hemoglobin's iron from ferrous iron to ferric iron, converting the hemoglobin into methaemoglobin. Cyanide is more strongly drawn to methaemoglobin than to the cytochrome oxidase of the cells, effectively pulling the cyanide off the cells and onto the methaemoglobin. Once bound with the cyanide, the Methaemoglobin becomes cyanmethaemoglobin. The next part of the cyanide antidote kit is sodium thiosulfate, which is administered intravenously. The sodium thiosulfate and cyanmethaemoglobin become thiocyanate, releasing the hemoglobin and the kidneys excrete the thiocyanate.


Content | Action | Initial Therapy | Specific Therapy | Warning


Corporate Philosophy
Troikaa Pharmaceuticals Limited is a young pharmaceutical company, which has acquired a reputation of an innovative company, over the years. We have been steadfastly sowing the basics of Innovation, Quality and Service to reap excellence.

Home | Company | Products | Technologies | International Business | Media Coverage | Human Resources | Research Publications | Partnering

Copyright ę 2009 Troikaa Pharmaceuticals Ltd. - Disclaimer